A, A., O, K. H., Z, B., P, B., AJ, C., L, H., . . . B, T. (2020). Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer. BJU international, 126(4), 433. https://doi.org/10.1111/bju.15151
Chicago Style (17th ed.) CitationA, Anton, et al. "Use of Prostate-specific Membrane Antigen Positron-emission Tomography/CT in Response Assessment Following Upfront Chemohormonal Therapy in Metastatic Prostate Cancer." BJU International 126, no. 4 (2020): 433. https://doi.org/10.1111/bju.15151.
MLA (9th ed.) CitationA, Anton, et al. "Use of Prostate-specific Membrane Antigen Positron-emission Tomography/CT in Response Assessment Following Upfront Chemohormonal Therapy in Metastatic Prostate Cancer." BJU International, vol. 126, no. 4, 2020, p. 433, https://doi.org/10.1111/bju.15151.